b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31237189</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Print">0001-5458</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>120</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Jun</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Acta chirurgica Belgica</Title>\n                <ISOAbbreviation>Acta Chir. Belg.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Investigating the prevalence of risk factors of papillary thyroid carcinoma recurrence and disease-free survival after thyroidectomy and central neck dissection in Iranian patients.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>173-178</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1080/00015458.2019.1576447</ELocationID>\n            <Abstract>\n                <AbstractText><b>Background:</b> Papillary thyroid carcinoma (PTC) is considered the most frequent thyroid malignancy (85-90%) with a good prognosis. However, its frequent recurrence increases mortality and morbidity. In this inquiry we investigated the prevalence of risk factors of PTC recurrence and disease free survival after thyroidectomy and central neck dissection. <b>Method:</b> In this retrospective study, all patients with confirmed PTC who underwent total thyroidectomy and central neck dissection in Imam Reza and Omid hospitals of Mashhad University of Medical Sciences from 2004 to 2011 were included. Total locoregional and distant recurrence rate, 5-year disease free survival rate (DFS) and contributing factors of recurrence were investigated after at least 5 years. <b>Results:</b> In this study 289 patients were included with a mean follow-up of 72.90 \xc2\xb1 11.02 months. 70.6% were female and 29.4% were male. Recurrence occurred in 58 cases from which 10 were distant and 48 were loco-regional. 5-year DFS was 80% and total-survival-rate was 99%. Our analysis showed that primary tumor size, vascular-invasion, extra-thyroid extension, and lymph node ratio (LNR) were significantly related to DFS.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Arianpoor</LastName>\n                    <ForeName>Arash</ForeName>\n                    <Initials>A</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5646-2333</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Asadi</LastName>\n                    <ForeName>Mehdi</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Amini</LastName>\n                    <ForeName>Elahe</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ziaeemehr</LastName>\n                    <ForeName>Aghigh</ForeName>\n                    <Initials>A</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6821-2358</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ahmadi Simab</LastName>\n                    <ForeName>Saeideh</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zakavi</LastName>\n                    <ForeName>Seyed Rasoul</ForeName>\n                    <Initials>SR</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>25</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Acta Chir Belg</MedlineTA>\n            <NlmUniqueID>0370571</NlmUniqueID>\n            <ISSNLinking>0001-5458</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Iran</Keyword>\n            <Keyword MajorTopicYN="N">Papillary thyroid carcinoma</Keyword>\n            <Keyword MajorTopicYN="N">central neck lymph nodes</Keyword>\n            <Keyword MajorTopicYN="N">disease-free survival</Keyword>\n            <Keyword MajorTopicYN="N">lymph node ratio</Keyword>\n            <Keyword MajorTopicYN="N">recurrence</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31237189</ArticleId>\n            <ArticleId IdType="doi">10.1080/00015458.2019.1576447</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'